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IGRT After Prostatectomy: Evaluation of 
Corrective Shifts and Toxicity Using Online 
Cone Beam CT vs. Weekly Port Films for 
Target Localization
Purpose/Objective(s)
Image guidance (IG) may permit higher radiotherapy (RT) doses 
(>65 Gy) after radical prostatectomy (RP) without increased toxicity, 
with improved accuracy and smaller margins. Conebeam (CBCT) 
allows IGRT with volumetric images. This study evaluated CBCT shifts 
and toxicity after conformal IGRT, compared to RT with port films.
Materials/Methods
After IRB approval, 68 consecutive patients who received post-RP RT 
(2005-2009) with CBCT were identified. Median dose was 68.4 Gy 
(R 66.6-70.2) delivered with 4-field, conformal IGRT. Online CBCT 
images were acquired 3-5 times weekly and were automatically 
co-registered to reference CT based on pelvic anatomy. Corrective 
shifts were made for deviations ≥5 mm. A comparative group was 
comprised of 150 patients who received post-RP RT (1990-2004) to a 
median of 64.8 Gy (R 59.4-68.4) with weekly port films. Genitourinary 
(GU) and gastrointestinal (GI) toxicity (RTOG grade (G) ≥ 2) was 
compared using Fisher’s exact test and odds ratio (OR) computed by 
logistic regression adjusted for dose. Two-way interactions were also 
investigated.
Results
CBCT mean shifts (SD) for 1053 fractions were 2.8 mm (2.8), 2.0 mm 
(2.4) & 3.1 mm (2.9) in the left-right (LR), anterior-posterior (AP) & 
superior-inferior (SI) axes, respectively. Shifts ≥ 5 mm were required 
for 15%, 6% & 19% of fractions in the LR, AP & SI axes, respectively. 
Late toxicity was evaluable in 43 patients (median follow-up 15 mo., 
R 3-46) in the CBCT group and 135 (median 74 mo., R 3-168) in the 
control group. GU and GI toxicity was largely G0-1. No G4 toxicity 
was reported. G2 & G3 acute GU toxicity was experienced by 13% 
(n=9) & 2% (n=1) of patients in the CBCT group, respectively, while 
13% (n=19) had G2 acute GU toxicity in the control group. G2 late 
GU toxicity was experienced by 7% (n=3) of patients in the CBCT 
group and 5% (n=7) in the control group. G2 acute GI toxicity was 
experienced by 13% (n=9) in the CBCT group and 15% (n=23) of 
controls. Late GI toxicity was G2 & G3 in 2% (n=1) & 2% (n=1) of 
patients in the CBCT group, respectively, while 1% (n=1) had G2 
toxicity in the control group. Acute GU (Fisher p=0.67) and GI 
(p=0.84) toxicity was not significantly different between the two 
groups. There was no association between acute GI toxicity and 
CBCT (p=0.74). Increased odds of acute GU toxicity were observed 
for doses > 68.4 Gy (interaction p=0.02), which were only delivered 
in the IGRT group.
Conclusion
Rates of acute toxicity with CBCT-guided post-RP RT to 68.4 Gy 
were similar to treatment to 64.8 Gy without IGRT. The higher rate 
of acute GU toxicity with doses > 68.4 Gy suggests a potential role for 
IMRT. IGRT with CBCT is associated with mostly G0-1 toxicity and 
minimal grade ≥ 2, suggesting that CBCT is a safe IG strategy. Longer 
follow-up is desired to compare late toxicity.
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